Source: MONTANA STATE UNIVERSITY submitted to
REDUCING THE ANTIBIOTIC RESISTANCE GENE RESERVOIR BY PLASMID CURING
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
TERMINATED
Funding Source
Reporting Frequency
Annual
Accession No.
1008009
Grant No.
2016-69003-24616
Project No.
MONW-2015-07852
Proposal No.
2015-07852
Multistate No.
(N/A)
Program Code
A4171
Project Start Date
Jan 1, 2016
Project End Date
Dec 31, 2017
Grant Year
2016
Project Director
Walk, S.
Recipient Organization
MONTANA STATE UNIVERSITY
(N/A)
BOZEMAN,MT 59717
Performing Department
Microbiology & Immunology
Non Technical Summary
Once bacteria have become resistant to antibiotics, they do not lose this resistance easily. Certain chemicals already approved to be safe in humans and animals at low levels may increase the rate that bacteria lose antibiotic resistance. This benefit may outweigh the use of such chemicals in agriculture by making foods safer for human consumption. This project will test whether SDS and menthol, two chemical compounds currently present in a variety of human foods and cosmetics, can be used to make bacteria in animals more sensitive to antibiotics.
Animal Health Component
0%
Research Effort Categories
Basic
50%
Applied
(N/A)
Developmental
50%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
7234099110075%
7123840106025%
Goals / Objectives
The long-term goal of this research is to decrease the reservoir of antibiotic resistance genes in food production animals by administration of bacterial plasmid curing compounds. This project will characterize in vitro plasmid curing activity of menthol and SDS on a well-characterized set of carbapenemase- and ESBL-producing Enterobacteriaceae. It will also determine whether administration of SDS and menthol can cure R-plasmids from ESBL-producing Enterobacteriaceae in mice.Specific objectives:1) Quantify plasmid loss under varying levels of plasmid curing agents (menthol and SDS), temperature (room temperature and mammalian and avian body temperature), and bacterial density (low and high).2) Co-culture R-plasmid carrying strains against R-plasmid cured counterparts to quantify differences in relative fitness.3) Colonize germ-free mice with R-plasmid carrying strains of Enterobacteriaceae and treat with plasmid curing agents (menthol and SDS).4) Quantify loss of R-plasmids in Enterobacteriaceae from mouse fecal pellets.5) Remove plasmid curing agents and monitor bacterial population dynamics to understand the longer-term effects of plasmid curing agents.
Project Methods
This project will use both in vitro and in vivo experimentation. Plasmid curing agents (SDS and menthol) will be used to decrease carriage of bacterial plasmids that encode antibiotic resistance genes. We will measure the impact of plasmid curing agents under a number of laboratory conditions and also their impact in animals that are colonized with antibiotic resistant bacteria. The data will take the form of the numbers of antibiotic resistant bacteria in the face of plasmid curing agents as well as the general health of experimental animals. A key milestone for this project will be determining how efficacious our approach will be in a mammalian how (i.e. how effective plasmid curing agents are in lab animals). We will evaluate the usefulness of our approach by comparing treatments to proper experimental controls and statistically significant loss of bacterial resistance will be the primary indication of success. During the course of investigation, undergraduate and graduate students will take part in conducting experiments and in formal discussion of the research progress and results during weekly laboratory meetings. As results are finalized, they will be communicated to scientists in the field through peer-reviewed manuscripts in major agricultural journals. Through these efforts, this project will help change current understanding and increase knowledge regarding active mitigation of antibiotic resistant bacteria in agriculture.

Progress 01/01/16 to 12/31/17

Outputs
Target Audience:Target audiences: 1) Undergraduate and graduate students through formal and informal research experiences in the laboratory. 2) Ag animal producers through published results in peer-reviewed journals and presentations at local, national and international meetings. 3) Ag policy makers and legislators through increased awareness of the impact of plasmid curing agents on antibiotic resistance in animals. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?A graduate student working on this project had the opportunity to learn about the ecology of plasmids in bacterial cells and how these factors influence the overall evolution of bacterial populations. This student performed PCR and DNA sequence based analyses to evaluate the impact of curing agents on plasmid abundance and distribution. The student also performed experiments without curing agents to understand the baseline nature of plasmids over time. This work will be highlighted in a manuscript of which the student will be the lead author. How have the results been disseminated to communities of interest?We are currently generating a manuscript describing our results and plan to submit to a peer-reviewed journal within the next two months. What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? Over the course of the project period, several experiments were conducted with R-plasmid containing Klebsiella and E. coli strains. Results from these experiments generated novel findings on the importance of plasmid-encoded toxin-antitoxin systems and other mechanisms by which these factors maintain themselves within host cells. We made significant discoveries regarding general rates of plasmid acquisition and loss both under laboratory conditions (in vitro) and in murine models (in vivo). A maunscript describing these results is being prepared for submission to a peer-reviewed journal. In general, most of the R-plasmids that were evaluated in our study contained factors (e.g. toxin-antitoxin systems) that largely overcame the curing effects of menthol and SDS. While these compounds were able to cure "simple" plasmids at rates exceeding the basal (random) curing rate, they were unable to cure R-plasmids that had evolved complex mechanisms to maintain themselves inside host bacterial cells. However, we learned enough about these plasmids to hypothesize which fators are important and so future work can focus on disrupting these genes either before curing agents are used or in conjunction with curing agents. One potential approach would be to use pathogen-specific phage to deliver CRISPR-mediated nucleases that disable toxin-antitoxin machinery. The added pressure for curing from menthol and SDS might then lead to the loss of R-plasmids in these populations. While not all of the project objectives were reached, a great deal of information and novel understanding came from this project and we look forward to publishing our results in the next few months.

Publications


    Progress 01/01/16 to 12/31/16

    Outputs
    Target Audience:Target audiences reached by the past year's efforts: 1) Undergraduate and graduate students through formal and informal research experiences in the laboratory. 2) Ag researchers through local presentations at local presentations of research results. Changes/Problems:We were excited to discover that plasmid content in our preliminary mouse experiments changed significantly over time even in the absence of exposure to plasmid curing agents. We were curious to know wether this happens in bacteria in people and have taken the opportunity to quantify plasmid content in E. coli isolated from fecal samples of several volunteers. This work has revealed many interesting observations that we continue to follow up on. Although this aspect of the project was unanticipated, we believe it is significant to the field and will advance the current understanding of plasmid mediated microbiome dynamics. However, this interesting sidebar will not detract from our ability to accomplish the goals of the proposed research and we are still on track to complete the proposed research by the end of the project period (12/31/2017). What opportunities for training and professional development has the project provided?Training - This project has provided an excellent opportunity for my graduate student to learn a number of molecular biology techniques. My lab manager and I have been able to instruct this student in plasmid preparations, PCR primer design, and murine modeling. Professional - I have increased my knowledge through individual study of the effects of plasmids on colonization of the murine gut. We think that our research will add significantly to this area and potentially lead to novel understanding of these genetic factors. How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?1) Quantify plasmid loss under varying levels of plasmid curing agents (menthol and SDS), temperature (room temperature and mammalian and avian body temperature), and bacterial density (low and high). All experiments to date have been at a high bacterial density and we will be conducting replicate experiments at lower density soon. 2) Co-culture R-plasmid carrying strains against R-plasmid cured counterparts to quantify differences in relative fitness. These exeriments have been started and are beginning to show interesting results. We anticipate completing this protion of the project in the next month and may be able to publish our findings if our initial observations are supported. 3) Colonize germ-free mice with R-plasmid carrying strains of Enterobacteriaceae and treat with plasmid curing agents (menthol and SDS). 4) Quantify loss of R-plasmids in Enterobacteriaceae from mouse fecal pellets. We will begin exposing resistant E. coli colonized mice to menthol and SDS and comparing the rate of R-plasmid loss to the rate that occurs spontaneously (i.e. without exposure to curing agents). We anticipate that these experiments will be completed by the end of this coming summer (2017). 5) Remove plasmid curing agents and monitor bacterial population dynamics to understand the longer-term effects of plasmid curing agents. These experiments will be conducted beginning in June 2017. We have begun to increase our breeding colony of mice to have an adequate of age- and sex-matched animals to accomplish this objective.

    Impacts
    What was accomplished under these goals? Specific objectives and accomplishments: 1) Quantify plasmid loss under varying levels of plasmid curing agents (menthol and SDS), temperature (room temperature and mammalian and avian body temperature), and bacterial density (low and high). We have tested the effects of menthol and SDS on ESBL-producing E. coli isolates at different temperatures. We have found variable effects upon repeat exposure to these agents, suggesting that chance events may be influencing our results. All experiments to date have been at a high bacterial density and we will be conducting replicate experiments at lower density soon. 2) Co-culture R-plasmid carrying strains against R-plasmid cured counterparts to quantify differences in relative fitness. We have begun to quantify fitness differences between isolates that have different plamsid content. Not enough experiments have been done to draw solid conclusions, but it appears that some isolates are more fit in the absence of antibiotic resistance plasmids. More results will help to clarify the outcome of this objective. 3) Colonize germ-free mice with R-plasmid carrying strains of Enterobacteriaceae and treat with plasmid curing agents (menthol and SDS). 4) Quantify loss of R-plasmids in Enterobacteriaceae from mouse fecal pellets. These two objectives are experimentally linked and are being pursued at the same time. Mice have been colonized with resistance E. coli and monitored for 12 weeks to evaluate colonization dynamics and the rate at which R-plasmids are lost simply by chance. We have shown that E. coli colonize GF mice rapidly and maintain a high level of abundance. We have also transplanted human stool samples into GF mice (i.e. humanized mice) and have shown that E. coli in this complex bacterial community are stable over a long period of time. We are now ready to begin exposing resistant E. coli colonized mice with the plasmid curing agents and comparing the rate of R-plasmid loss. 5) Remove plasmid curing agents and monitor bacterial population dynamics to understand the longer-term effects of plasmid curing agents. We have not yet conducted these experiments, but plan to begin in a few weeks time.

    Publications